State Courts Are Winning Big in NEC Baby Formula Cases—Here's What Families Need to Know

Families whose premature babies developed necrotizing enterocolitis (NEC) after being fed cow milk-based infant formulas like Similac and Enfamil are seeing significant legal victories in state courts, with juries awarding hundreds of millions in damages. These cases allege that formula manufacturers knew the risks to vulnerable newborns but failed to warn hospitals and medical professionals. The shift toward state court litigation is reshaping how these cases unfold and what families can expect.

What Is Necrotizing Enterocolitis and Why Does It Matter?

Necrotizing enterocolitis is a serious intestinal condition that primarily affects premature infants. The disease causes inflammation and tissue death in the bowel, sometimes requiring surgical removal of damaged sections. Babies who survive NEC often face lifelong complications, including short gut syndrome, which requires tube feeding and ongoing medical care. Some infants don't survive the condition at all.

According to litigation documents and medical literature cited in ongoing NEC cases, research has linked cow milk-based formulas to increased NEC risk in premature infants. The lawsuits center on whether formula manufacturers like Abbott (maker of Similac) and Mead Johnson (maker of Enfamil) knew about this risk and failed to adequately warn hospitals, neonatal intensive care units (NICUs), and medical professionals who make feeding decisions for medically fragile newborns.

How Are State Courts Outpacing Federal Litigation?

While roughly 800 NEC cases remain pending in federal court as part of a multidistrict litigation (MDL), state courts have already produced tangible results. A Missouri jury awarded $495 million against Similac, and an Illinois jury awarded $60 million against Enfamil's manufacturer. State court verdicts suggest that juries can grasp the complexities of NEC litigation, as some observers had questioned whether jurors would understand the medical and legal issues involved.

The federal MDL has moved more slowly, with dismissed bellwether cases and ongoing disputes over expert testimony. The next round of federal trials isn't expected until August 2026. Meanwhile, state courts are pushing forward with cases, and judges are allowing them to proceed. This momentum is why plaintiffs' lawyers increasingly prefer state court, where juries have already shown they can understand these complex cases.

What Are the Key Arguments in These Cases?

Families suing formula manufacturers make several core allegations:

• Knowledge of Risk: Abbott and Mead Johnson knew for years that cow milk-based formulas increased the risk of NEC in premature infants but continued selling the products into hospitals without adequate warnings.
• Failure to Warn: The companies did not provide sufficient warnings to hospitals, NICU staff, and medical professionals who make feeding decisions for vulnerable premature babies.
• Permanent Harm: Infants who developed NEC after being fed these formulas suffered permanent, life-altering injuries, including loss of bowel function and the need for lifelong medical care.

Abbott's primary defense argues that failure-to-warn claims don't hold because parents didn't see the label when formula was given in the NICU. However, plaintiffs' lawyers counter that this defense misses the point entirely. The intended audience for warnings was never parents shopping at a grocery store—it was hospitals, NICU staff, and the medical community making critical feeding decisions for medically fragile premature babies.

How to Protect Your Premature Infant's Health

• Discuss Formula Choices with Your NICU Team: If your baby is in the NICU, talk with your medical team about all available feeding options and any known risks associated with different formulas. Ask specifically about the ingredients and whether there are alternatives to cow milk-based formulas.
• Monitor for NEC Symptoms: Learn to recognize early signs of NEC, including abdominal distention, feeding intolerance, and changes in bowel movements. Report any concerns immediately to your healthcare provider, as early intervention can limit bowel damage.
• Keep Detailed Medical Records: Maintain comprehensive records of which formulas your baby received in the hospital, any symptoms that developed, and all medical interventions. These records are essential if you later need to pursue legal action.
• Seek Legal Consultation if Needed: If your premature baby developed NEC after being fed Similac or Enfamil, consult with a lawyer experienced in NEC cases to understand your options and whether your family qualifies for compensation.

What Should Families Know About Pursuing Legal Action?

If your premature baby was diagnosed with NEC after being fed Similac or Enfamil formula, you may be eligible to participate in a class action lawsuit or individual case against the formula manufacturers. Families who have suffered as a result of NEC linked to these formulas can potentially receive financial compensation for medical expenses, loss of bowel function, ongoing care needs, and other damages.

Time may be limited to bring an NEC lawsuit, so families should act promptly. Legal representation is available in all 50 states, and many law firms offer free case evaluations to determine whether your family qualifies. The strength of state court verdicts suggests that families have a meaningful opportunity to hold manufacturers accountable and receive compensation for the harm their children have endured.

What Does This Mean for the Future of Infant Formula Safety?

The ongoing NEC litigation is reshaping how formula manufacturers approach product safety and transparency. State court victories are creating settlement pressure on companies, potentially leading to changes in how formulas are marketed to hospitals and how risks are communicated to medical professionals. As more cases proceed through state courts, the legal landscape continues to shift in favor of families seeking accountability.

For parents of premature infants, these cases underscore the importance of informed decision-making about feeding options and the value of staying informed about product safety issues. While NEC is a serious condition, awareness and early medical intervention can make a significant difference in outcomes.